Insiders · Profile

OrbiMed Israel GP Ltd.

10% owner at Chemomab Therapeutics · 10% owner at Eledon Pharmaceuticals. Filing since 2 May 2019. CIK 0001569590

Company
Date
Role
Action
Shares
Amount
Of holding
3 Jan 2023
10% owner
Sold, plan not stated
336,900
$1.21M
13.1%
2 Dec 2020
10% owner
Sold, plan not stated
103,200
$2.23M
58.4%
2 May 2019
Director
Bought
646,204
$2.00M
25.5%
3 decisions on file.